(Q35807240)

10 August 2017

1 reference

title

Management of fatigue in patients with multiple sclerosis (English)

1 reference

10 August 2017

0 references

Udo A Zifko

1

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

64

1 reference

10 August 2017

12

1 reference

10 August 2017

1295-1304

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464120-00003

10 August 2017

0 references

cites work

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea

1 reference

12 December 2020

Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment

1 reference

12 December 2020

Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

1 reference

12 December 2020

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

1 reference

12 December 2020

An electrophysiological study of the mechanism of fatigue in multiple sclerosis.

1 reference

12 December 2020

German version of the Epworth Sleepiness Scale.

1 reference

12 December 2020

Prospective study of neurorehabilitation in multiple sclerosis

1 reference

12 December 2020

Modafinil for excessive daytime sleepiness in myotonic dystrophy

1 reference

12 December 2020

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

1 reference

12 December 2020

Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil

1 reference

12 December 2020

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

1 reference

12 December 2020

Chronic fatigue syndrome--aetiological aspects

1 reference

12 December 2020

Is fatigue in patients with multiple sclerosis related to autonomic dysfunction?

1 reference

12 December 2020

Amantadine, fatigue, and multiple sclerosis

1 reference

12 December 2020

The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study

1 reference

12 December 2020

Sexual dysfunction in multiple sclerosis: II. Correlation analysis.

1 reference

12 December 2020

Therapy of day time fatigue in patients with multiple sclerosis

1 reference

12 December 2020

Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT.

1 reference

12 December 2020

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

1 reference

12 December 2020

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

1 reference

12 December 2020

Motor control of the diaphragm in multiple sclerosis

1 reference

12 December 2020

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

1 reference

12 December 2020

Who makes the most progress in inpatient rehabilitation? An analysis of functional gain

1 reference

12 December 2020

Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis

1 reference

12 December 2020

['Fatigue' in multiple sclerosis]

1 reference

12 December 2020

Neuromuscular responses of patients with multiple sclerosis

1 reference

12 December 2020

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

1 reference

12 December 2020

'Fatigue' in patients with multiple sclerosis. Motor pathway conduction and event-related potentials

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis.

1 reference

12 December 2020

Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis

1 reference

12 December 2020

Physiopathology and treatment of fatigue in multiple sclerosis

1 reference

12 December 2020

Double-blind study of pulsing magnetic field effects on multiple sclerosis

1 reference

12 December 2020

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

12 December 2020

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

1 reference

12 December 2020

The impact of inpatient rehabilitation on progressive multiple sclerosis

1 reference

12 December 2020

An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis.

1 reference

12 December 2020

Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis

1 reference

12 December 2020

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

1 reference

12 December 2020

Amantadine treatment of fatigue associated with multiple sclerosis

1 reference

12 December 2020

Treatments for fatigue in multiple sclerosis: a rapid and systematic review

1 reference

12 December 2020

10.2165/00003495-200464120-00003

Identifiers

DOI

1 reference

PubMed ID

15200345

Dimensions Publication ID

10 August 2017

0 references

1 reference

PubMed ID

15200345